Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
2.52
Dollar change
+0.01
Percentage change
0.40
%
Index- P/E- EPS (ttm)-4.30 Insider Own26.31% Shs Outstand26.45M Perf Week21.74%
Market Cap67.56M Forward P/E- EPS next Y-2.60 Insider Trans2.40% Shs Float19.76M Perf Month30.57%
Income-131.56M PEG- EPS next Q-0.67 Inst Own56.07% Short Float4.82% Perf Quarter-53.93%
Sales4.15M P/S16.28 EPS this Y70.57% Inst Trans-10.57% Short Ratio2.28 Perf Half Y-51.54%
Book/sh-0.24 P/B- EPS next Y-51.81% ROA-91.46% Short Interest0.95M Perf Year1.20%
Cash/sh2.95 P/C0.86 EPS next 5Y- ROE-393.39% 52W Range1.43 - 8.17 Perf YTD-67.65%
Dividend Est.- P/FCF- EPS past 5Y21.16% ROI-253.91% 52W High-69.16% Beta1.62
Dividend TTM- Quick Ratio3.46 Sales past 5Y128.79% Gross Margin62.39% 52W Low76.22% ATR (14)0.24
Dividend Ex-Date- Current Ratio3.46 EPS Y/Y TTM22.30% Oper. Margin-2835.68% RSI (14)62.74 Volatility14.59% 9.80%
Employees68 Debt/Eq- Sales Y/Y TTM-53.52% Profit Margin-3171.70% Recom1.00 Target Price8.75
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q54.27% Payout- Rel Volume0.70 Prev Close2.51
Sales Surprise955.56% EPS Surprise76.34% Sales Q/Q-100.00% EarningsOct 31 BMO Avg Volume417.46K Price2.52
SMA2019.37% SMA5032.02% SMA200-47.02% Trades Volume290,726 Change0.40%
Date Action Analyst Rating Change Price Target Change
Nov-04-20Upgrade H.C. Wainwright Neutral → Buy $11 → $15
Sep-22-20Initiated Alliance Global Partners Buy $18
Jan-17-20Downgrade Wedbush Outperform → Neutral
Mar-08-19Resumed JMP Securities Mkt Outperform $18
Feb-14-19Resumed Oppenheimer Outperform $13
Nov-05-18Upgrade ROTH Capital Neutral → Buy
Mar-13-18Reiterated Wedbush Outperform $11 → $13
Oct-31-17Resumed Piper Jaffray Overweight $30
Oct-23-17Initiated ROTH Capital Neutral $15
Aug-10-17Downgrade JMP Securities Mkt Outperform → Mkt Perform
Today 07:30AM
Oct-24-24 07:08AM
Oct-09-24 03:33PM
Sep-12-24 07:00PM
07:00PM
07:00AM Loading…
Aug-27-24 07:00AM
Aug-14-24 10:19AM
09:35AM
Aug-13-24 09:41AM
09:13AM
Aug-12-24 04:15PM
Aug-05-24 09:55AM
Jul-31-24 07:30AM
Jul-24-24 07:00AM
Jul-17-24 11:24AM
08:00AM Loading…
08:00AM
Jun-13-24 07:00AM
May-15-24 03:03AM
01:14AM
May-14-24 10:52AM
07:30AM
May-07-24 09:00AM
07:00AM
May-01-24 10:01AM
Apr-10-24 09:49AM
08:30AM
Apr-09-24 07:00AM
Apr-02-24 04:30PM
Mar-28-24 10:06AM
Mar-27-24 11:53AM
07:30AM Loading…
07:30AM
Mar-25-24 07:00AM
Mar-20-24 07:00AM
Feb-27-24 07:00AM
Jan-31-24 04:00PM
Jan-19-24 10:43AM
Jan-18-24 12:00PM
Jan-17-24 08:50AM
Jan-16-24 12:00PM
09:55AM
Jan-11-24 08:48AM
Jan-08-24 07:00AM
Jan-03-24 11:03PM
Dec-19-23 07:27AM
Dec-07-23 09:44AM
Dec-06-23 07:00AM
Dec-03-23 04:17PM
Nov-21-23 07:30AM
Nov-15-23 01:08PM
Nov-14-23 07:30AM
Nov-07-23 07:30AM
Oct-02-23 08:45AM
Sep-07-23 04:30PM
Aug-08-23 09:49PM
09:05AM
07:30AM
Aug-04-23 04:30PM
Aug-01-23 07:30AM
Jul-27-23 06:29AM
Jul-21-23 05:40PM
Jul-05-23 04:30PM
Jun-22-23 08:14PM
Jun-13-23 08:00AM
Jun-08-23 07:30AM
Jun-01-23 04:30PM
May-25-23 05:05PM
08:44AM
May-13-23 10:15AM
May-10-23 10:08PM
08:45AM
07:30AM
May-09-23 07:00AM
May-07-23 08:40PM
May-03-23 07:30AM
May-02-23 07:00AM
Mar-06-23 09:48AM
Mar-04-23 07:08AM
Mar-02-23 10:02PM
09:35AM
07:30AM
Feb-28-23 07:30AM
Feb-23-23 07:30AM
Feb-09-23 04:05PM
Feb-01-23 09:43AM
Jan-26-23 07:00AM
Jan-09-23 07:00AM
Dec-23-22 04:05PM
Dec-16-22 06:47AM
Dec-12-22 07:30AM
Dec-10-22 10:00AM
Dec-05-22 07:00AM
Nov-22-22 07:30AM
Nov-14-22 08:45AM
07:30AM
Nov-07-22 07:30AM
Nov-04-22 04:30PM
Nov-03-22 09:01AM
Oct-05-22 04:01PM
Sep-23-22 12:00PM
Sep-16-22 04:05PM
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chee ConleyPresident & CEOSep 11 '24Buy1.7150,00085,420122,504Sep 12 05:00 PM
Haas JasonChief Financial OfficerSep 12 '24Buy1.6845,34476,006124,552Sep 12 05:00 PM
Chee ConleyPresident & CEOSep 10 '24Buy1.5150,00075,26072,504Sep 12 05:00 PM
Haas JasonChief Financial OfficerSep 10 '24Buy1.5535,36354,78859,915Sep 12 05:00 PM
Haas JasonChief Financial OfficerSep 11 '24Buy1.5819,29330,44679,208Sep 12 05:00 PM
Young Richard ADirectorJun 28 '24Sale5.1234,837178,3658,000Jul 02 04:15 PM
Roth DavidChief Medical OfficerApr 03 '24Sale4.9510,45151,7320Apr 05 04:30 PM
Roth DavidChief Medical OfficerApr 02 '24Sale4.9815074710,451Apr 02 04:58 PM
AKKARAJU SRINIVASDirectorDec 21 '23Buy4.42904,9773,999,9981,786,427Dec 26 05:24 PM
Roth DavidChief Medical OfficerDec 12 '23Sale4.956,28731,1210Dec 14 04:24 PM
Roth DavidChief Medical OfficerDec 06 '23Sale3.956,28724,8346,287Dec 08 04:23 PM